Literature DB >> 27075332

CORR Insights®: Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.

David M King1.   

Abstract

Mesh：

Year:  2016        PMID： 27075332      PMCID： PMC5289177          DOI： 10.1007/s11999-016-4831-2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  6 in total

1.  Customized treatment algorithm for giant cell tumor of bone: report of a series.

Authors:  William G Ward; Galaxy Li
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

2.  Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results.

Authors:  K Szalay; I Antal; J Kiss; M Szendroi
Journal:  Int Orthop       Date:  2006-09-13       Impact factor: 3.075

3.  Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.

Authors:  Wolfgang T Becker; Jörn Dohle; Ludger Bernd; Arnim Braun; Miklos Cserhati; Alfred Enderle; Louis Hovy; Zdenek Matejovsky; Miklos Szendroi; Klemens Trieb; Per-Ulf Tunn
Journal:  J Bone Joint Surg Am       Date:  2008-05       Impact factor: 5.284

4.  Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?

Authors:  Lizz van der Heijden; Michiel A J van de Sande; Adriaan C Heineken; Marta Fiocco; Rob G H H Nelissen; P D Sander Dijkstra
Journal:  J Bone Joint Surg Am       Date:  2013-11-06       Impact factor: 5.284

Review 5.  Recurrence of giant-cell tumors of the long bones after curettage and packing with cement.

Authors:  R J O'Donnell; D S Springfield; H K Motwani; J E Ready; M C Gebhardt; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1994-12       Impact factor: 5.284

6.  Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement.

Authors:  Zhen-hua Gao; Jun-qiang Yin; Xian-biao Xie; Chang-ye Zou; Gang Huang; Jin Wang; Jing-nan Shen
Journal:  BMC Musculoskelet Disord       Date:  2014-10-02       Impact factor: 2.362
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.